Probiotic Supplements Show Promise for Improving Sleep and Motor Symptoms in Parkinson’s

A small new study tested whether probiotic supplementation could help people with Parkinson’s who also experience REM Sleep Behavior Disorder (RBD) and motor symptoms. Researchers enrolled fifty individuals with PD and randomly assigned them to receive either probiotics or standard care, while continuing their usual medications. Their goal was to see whether probiotics could improve both sleep-related behaviors and physical symptoms—and whether those changes would link to shifts in gut bacteria or blood metabolites. After 12 weeks, the group taking probiotics showed meaningful improvements in two key measures compared to the control group. On the Unified Parkinson’s Disease Rating Scale (UPDRS), which tracks motor symptoms, scores in the probiotic group improved by nearly five points, while the control group’s scores showed no meaningful change. For RBD symptoms—where people physically act out their dreams during REM sleep—the probiotic group improved by about seven points, whereas the control group remained stable. The researchers also examined changes in gut microbiome profiles and blood metabolites. Those supplemented with probiotics had notable shifts in gut bacteria, including increases in beneficial groups like Actinobacteria and Bacillus, and decreases in others linked to disease. In the bloodstream, they found that probiotic supplementation altered several metabolites—small molecules that circulate in the blood and may influence brain and nerve function. While this was a pilot study, and the sample size was small, the results are encouraging: probiotic supplements appeared to ease both motor symptoms and dream-related sleep disturbances in people with Parkinson’s. The improvements coincided with measurable changes in gut bacteria and blood chemistry, suggesting a possible gut-brain interaction at work. This aligns with growing evidence that gut health plays a role in Parkinson’s. Gut dysbiosis—an imbalance of bacteria—has been linked to inflammation and neurological symptoms in PD. By shifting the composition of gut microbiota, probiotics may help modulate inflammation, improve motor function, and regulate sleep patterns. Of course, larger, more rigorous trials are needed before probiotics can be recommended as a standard Parkinson’s therapy. But this pilot study offers a hopeful glimpse: a relatively simple dietary supplement may offer relief for troubling non-motor symptoms and open a door toward gut-centered approaches in PD care.